Confluent (NASDAQ:CFLT - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.28), Zacks reports. Confluent had a negative net margin of 38.35% and a negative return on equity of 34.05%. Confluent updated its FY 2025 guidance to 0.350-0.350 EPS and its Q1 2025 guidance to 0.060-0.070 EPS.
Confluent Stock Performance
NASDAQ:CFLT traded down $1.36 during mid-day trading on Tuesday, reaching $30.10. The company's stock had a trading volume of 10,744,093 shares, compared to its average volume of 4,296,510. Confluent has a 12-month low of $17.79 and a 12-month high of $35.07. The stock has a market cap of $9.87 billion, a P/E ratio of -27.12 and a beta of 0.92. The company has a current ratio of 4.24, a quick ratio of 4.24 and a debt-to-equity ratio of 1.17. The firm's fifty day moving average price is $29.52 and its two-hundred day moving average price is $25.25.
Analyst Ratings Changes
Several research firms recently weighed in on CFLT. Barclays lifted their price target on shares of Confluent from $32.00 to $35.00 and gave the company an "overweight" rating in a report on Friday, December 6th. JPMorgan Chase & Co. boosted their target price on shares of Confluent from $35.00 to $38.00 and gave the company an "overweight" rating in a report on Wednesday, December 11th. Wells Fargo & Company boosted their target price on shares of Confluent from $35.00 to $40.00 and gave the company an "overweight" rating in a report on Thursday, December 5th. Robert W. Baird boosted their target price on shares of Confluent from $23.00 to $28.00 and gave the company a "neutral" rating in a report on Thursday, October 31st. Finally, Guggenheim boosted their target price on shares of Confluent from $32.00 to $35.00 and gave the company a "buy" rating in a report on Friday, January 31st. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $32.30.
Check Out Our Latest Stock Analysis on Confluent
Insider Activity
In other news, Director Matthew Craig Miller sold 1,084,259 shares of the company's stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $28.90, for a total transaction of $31,335,085.10. Following the completion of the sale, the director now owns 12,559 shares of the company's stock, valued at $362,955.10. This represents a 98.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CMO Stephanie Buscemi sold 5,271 shares of the company's stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $28.23, for a total transaction of $148,800.33. Following the sale, the chief marketing officer now directly owns 144,373 shares of the company's stock, valued at $4,075,649.79. The trade was a 3.52 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 2,825,395 shares of company stock valued at $85,343,808 in the last quarter. 13.82% of the stock is currently owned by insiders.
Confluent Company Profile
(
Get Free Report)
Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.
See Also
![Earnings History for Confluent (NASDAQ:CFLT)](https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&Symbol=CFLT)
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider Confluent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Confluent wasn't on the list.
While Confluent currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.